Condition
Functional Bowel Disorders
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02498301Not ApplicableCompleted
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
NCT00617396Not ApplicableCompletedPrimary
Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder
NCT01262755Completed
Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology
NCT01064661Not ApplicableCompleted
Pilot Study Studying Physiological Effects of Probiotic Pills in Patients With Abdominal Pain/Discomfort and Bloating
Showing all 4 trials